BB Biotech AG BION
Dividend Summary
The next BB Biotech AG dividend is expected to go ex in 12 months and to be paid in 12 months.
The previous BB Biotech AG dividend was 180c and it went ex 7 days ago and it was paid 3 days ago.
There is typically 1 dividend per year (excluding specials).
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | Forecast |
| Type | Final | Final |
| Per share | 180c | Sign Up Required |
| Declaration date | 19 Feb 2025 (Wed) | 18 Feb 2026 (Wed) |
| Ex-div date | 21 Mar 2025 (Fri) | 20 Mar 2026 (Fri) |
| Pay date | 25 Mar 2025 (Tue) | 24 Mar 2026 (Tue) |
Enter the number of BB Biotech AG shares you hold and we'll calculate your dividend payments:
Sign up for BB Biotech AG and we'll email you the dividend information when they declare.
Add BB Biotech AG to receive free notifications when they declare their dividends.
Your account is set up to receive BB Biotech AG notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Forecast | Final | 16 Feb 2028 | 17 Mar 2028 | 21 Mar 2028 | CHF | Sign up | — | |
| Forecast | Final | 17 Feb 2027 | 19 Mar 2027 | 23 Mar 2027 | CHF | Sign up | — | |
| Forecast | Final | 18 Feb 2026 | 20 Mar 2026 | 24 Mar 2026 | CHF | Sign up | — | |
| Paid | Final | 19 Feb 2025 | 21 Mar 2025 | 25 Mar 2025 | CHF | 200c | 180c | 😏 |
| Paid | Final | 07 Feb 2024 | 25 Mar 2024 | 27 Mar 2024 | CHF | 285c | 200c | 😞 |
| Paid | Final | 20 Jan 2023 | 27 Mar 2023 | 29 Mar 2023 | CHF | 410c | 285c | 😞 |
| Paid | Final | 28 Jan 2022 | 21 Mar 2022 | 23 Mar 2022 | CHF | 400c | 385c | 😃 |
| Paid | Final | 22 Jan 2021 | 22 Mar 2021 | 24 Mar 2021 | CHF | 352c | 360c | 😃 |
| Paid | Final | 20 Jan 2020 | 23 Mar 2020 | 25 Mar 2020 | CHF | 310c | 340c | 😊 |
| Paid | Final | 23 Jan 2019 | 25 Mar 2019 | 27 Mar 2019 | CHF | — | 305c | |
| Paid | Final | 23 Jan 2018 | 15 Mar 2018 | 19 Mar 2018 | CHF | — | 330c | |
| Paid | Final | 20 Jan 2017 | 20 Mar 2017 | 22 Mar 2017 | CHF | — | 275c | |
| Paid | Special | 27 Feb 2016 | 21 Mar 2016 | 23 Mar 2016 | CHF | — | 1225c | |
| Paid | Final | 19 Feb 2016 | 21 Mar 2016 | 23 Mar 2016 | CHF | — | 225c | |
| Paid | Special | 26 Jan 2015 | 20 Mar 2015 | 24 Mar 2015 | CHF | — | 1160c | |
| Paid | Special | 27 Jan 2014 | 21 Mar 2014 | 26 Mar 2014 | CHF | — | 700c | |
| Paid | Special | 25 Feb 2013 | 20 Mar 2013 | 25 Mar 2013 | CHF | — | 450c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 0.0c | 0% |
| 2013 | 0.0c | 0% |
| 2014 | 0.0c | 0% |
| 2015 | 225.0c | 100% |
| 2016 | 275.0c | 22.2% |
| 2017 | 330.0c | 20.0% |
| 2018 | 305.0c | -7.6% |
| 2019 | 340.0c | 11.5% |
| 2020 | 360.0c | 5.9% |
| 2021 | 385.0c | 6.9% |
| 2022 | 285.0c | -26.0% |
| 2023 | 200.0c | -29.8% |
| 2024 | 180.0c | -10.0% |
| 2025 | Sign Up Required | |
| 2026 | Sign Up Required | |
| 2027 | Sign Up Required | |
BB Biotech AG Optimized Dividend Chart
- Dividend Yield Today
- 5.7%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 7.8% on 20 March 2025
- 52 Week Low
- 4.4% on 28 March 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About BB Biotech AG
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Switzerland
- Share Price
- Fr.31.80 (yesterday's closing price)
- Shares in Issue
- 55 million
- Market Cap
- Fr.1.8bn
- 0
- Market Indices
- STOXX600
